Research and analysis

Power frequency electromagnetic fields (EMFs): melatonin and risk of breast cancer

This AGNIR report (RCE-1) considers the scientific evidence from studies relating to power frequency EMFs, melatonin and the risk of breast cancer.

From:
Public Health England
Published
1 February 2006

Documents

RCE-1: power frequency electromagnetic fields, melatonin and the risk of breast cancer

Ref: ISBN 0-85951-573-7

PDF, 1.39 MB, 180 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Exposure to power frequency electromagnetic fields (EMFs) is ubiquitous in modern life. It was suggested in the late 1980s that chronic exposure to EMFs may increase the risk of breast cancer, via a reduction in secretion of the hormone melatonin from the pineal gland. To review this hypothesis, this report by the Advisory Group on Non-ionising Radiation (AGNIR) addresses evidence on whether:

  • EMFs affect the production or action of melatonin
  • melatonin affects the risk of breast cancer
  • EMFs affect the risk of breast cancer

This 2006 report contains health-related conclusions and research recommendations based on the scientific evidence.

Published 1 February 2006

Related content